Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
Vitae Pharmaceuticals, Inc (VTAE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/25/2016 |
4
| Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
4
| LEONARD JOHN M. (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
4
| Sable Carole (Chief Medical Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| HAYDEN DONALD J JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| JUNIUS DANIEL M (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Disposed/sold 20,000 options to buy
@ $11.37, valued at
$227.4k
|
|
| 10/25/2016 |
4
| Bernstein Karen (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| Fratamico Arthur (Chief Business Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| SANTINI GINO (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Disposed/sold 17,000 options to buy
@ $8, valued at
$136k
Disposed/sold 10,000 options to buy
@ $12.43, valued at
$124.3k
Disposed/sold 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
4
| Applebaum Scott (General Counsel) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/21/2016 |
4
| Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 09/16/2016 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 09/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| Fratamico Arthur (Chief Business Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 08/17/2016 |
4
| Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 08/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 08/12/2016 |
4
| Applebaum Scott (General Counsel) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 07/27/2016 |
4
| JUNIUS DANIEL M (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 20,000 options to buy
@ $11.37, valued at
$227.4k
|
|
| 06/08/2016 |
4
| Sable Carole (Chief Medical Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 150,000 options to buy
@ $10.51, valued at
$1.6M
|
|
| 05/27/2016 |
4
| Gunderson Robert V JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 05/27/2016 |
4
| SANTINI GINO (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 05/27/2016 |
4
| Bernstein Karen (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 05/27/2016 |
4
| ROBERTS BRYAN E (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 05/27/2016 |
4
| HAYDEN DONALD J JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 05/27/2016 |
4
| Rowland Charles A Jr (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 05/27/2016 |
4
| LEONARD JOHN M. (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 03/21/2016 |
4
| HAYDEN DONALD J JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Sold 16,130 shares
@ $7.42, valued at
$119.7k
Exercised 1,935 options to buy
@ $3.45, valued at
$6.7k
Exercised 14,195 options to buy
@ $3.45, valued at
$49k
|
|
| 02/16/2016 |
4
| Gregg Richard (Chief Scientific Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 32,750 options to buy
@ $8.58, valued at
$281k
|
|
| 02/16/2016 |
4
| Morris Richard Steven (CFO) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 27,500 options to buy
@ $8.58, valued at
$236k
|
|
| 02/16/2016 |
4
| Fratamico Arthur (Chief Business Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 19,250 options to buy
@ $8.58, valued at
$165.2k
|
|
|
|
|